FLR
62
3
UAL
66
5
SBUX
39
4
PEG
53
3
NAVI
30
-22
R
67
4
FTI
61
-3
HBI
64
2
O
40
-24
ADT
60
-6
ZBH
68
2
BAC
63
3
MET
53
-20
K
45
-23
NFLX
48
-20
XYL
62
4
UA
33
3
COST
44
3
SJM
45
2
MCO
62
-16
FLR
62
3
UAL
66
5
SBUX
39
4
PEG
53
3
NAVI
30
-22
R
67
4
FTI
61
-3
HBI
64
2
O
40
-24
ADT
60
-6
ZBH
68
2
BAC
63
3
MET
53
-20
K
45
-23
NFLX
48
-20
XYL
62
4
UA
33
3
COST
44
3
SJM
45
2
MCO
62
-16
Financhill
Back

Logitech International SA Vs. Kymera Therapeutics Industry Stock Comparison

Sell
41

LOGI
Logitech International SA

Last Price:
$94.54
Seasonality Move:
-1.43%
Buy
77

KYMR
Kymera Therapeutics

Last Price:
$44.22
Seasonality Move:
-8.02%
Sell
41
Logitech International SA (LOGI) is a Sell

Is Logitech International SA a Buy, Sell or Hold?

  • The current Logitech International SA [LOGI] share price is $96.77. The Score for LOGI is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • LOGI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $45.79. The Score for KYMR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LOGI Stock Price Chart

What is Logitech International SA's stock price today?

  • The Logitech International SA share price today is $96.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LOGI is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $45.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.

LOGI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.72 Buy
Relative Strength Index (14 RSI): 66.04 Buy
Chaikin Money Flow: 421929 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (89.09 - 96.07) Buy
Bollinger Bands (100): (77.7 - 93.58) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.65 Buy
Relative Strength Index (14 RSI): 56.87 Buy
Chaikin Money Flow: 15209 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.33 - 46.23) Buy
Bollinger Bands (100): (27.72 - 44.14) Buy

LOGI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 96.01 Buy
20-day SMA: 94 Buy
50-day SMA: 89.08 Buy
200-day SMA: 86.55 Buy
8-day EMA: 21.5 Buy
20-day EMA: 9.22 Buy
50-day EMA: 3.79 Buy
200-day EMA: 0.96 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.88 Sell
20-day SMA: 45.02 Buy
50-day SMA: 41.89 Buy
200-day SMA: 39.32 Buy
8-day EMA: 10.18 Buy
20-day EMA: 4.36 Buy
50-day EMA: 1.8 Buy
200-day EMA: 0.46 Buy

Logitech International SA Earnings Growth & LOGI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.86 per share, and a decrease next year of $0.22 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.65 per share, and a decrease next year of $0.51 per share.

Logitech International SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):